2-43872255-C-T

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6

The NM_022437.3(ABCG8):​c.1160C>T​(p.Pro387Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000667 in 1,613,868 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00038 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00070 ( 1 hom. )

Consequence

ABCG8
NM_022437.3 missense

Scores

1
18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:7B:4

Conservation

PhyloP100: -1.89
Variant links:
Genes affected
ABCG8 (HGNC:13887): (ATP binding cassette subfamily G member 8) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the White subfamily. The protein encoded by this gene functions to exclude non-cholesterol sterol entry at the intestinal level, promote excretion of cholesterol and sterols into bile, and to facilitate transport of sterols back into the intestinal lumen. It is expressed in a tissue-specific manner in the liver, intestine, and gallbladder. This gene is tandemly arrayed on chromosome 2, in a head-to-head orientation with family member ABCG5. Mutations in this gene may contribute to sterol accumulation and atherosclerosis, and have been observed in patients with sitosterolemia. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.039331645).
BP6
Variant 2-43872255-C-T is Benign according to our data. Variant chr2-43872255-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 500519.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=6}. Variant chr2-43872255-C-T is described in Lovd as [Likely_benign].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ABCG8NM_022437.3 linkuse as main transcriptc.1160C>T p.Pro387Leu missense_variant 8/13 ENST00000272286.4 NP_071882.1 Q9H221-1
ABCG8NM_001357321.2 linkuse as main transcriptc.1157C>T p.Pro386Leu missense_variant 8/13 NP_001344250.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ABCG8ENST00000272286.4 linkuse as main transcriptc.1160C>T p.Pro387Leu missense_variant 8/131 NM_022437.3 ENSP00000272286.2 Q9H221-1
ABCG8ENST00000644611.1 linkuse as main transcriptc.1172C>T p.Pro391Leu missense_variant 8/9 ENSP00000495423.1 A0A2R8Y6M1

Frequencies

GnomAD3 genomes
AF:
0.000381
AC:
58
AN:
152178
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000647
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000482
AC:
121
AN:
250998
Hom.:
1
AF XY:
0.000508
AC XY:
69
AN XY:
135710
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00101
Gnomad FIN exome
AF:
0.0000924
Gnomad NFE exome
AF:
0.000714
Gnomad OTH exome
AF:
0.000490
GnomAD4 exome
AF:
0.000697
AC:
1019
AN:
1461690
Hom.:
1
Cov.:
32
AF XY:
0.000690
AC XY:
502
AN XY:
727130
show subpopulations
Gnomad4 AFR exome
AF:
0.000119
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.000765
Gnomad4 FIN exome
AF:
0.0000939
Gnomad4 NFE exome
AF:
0.000820
Gnomad4 OTH exome
AF:
0.000447
GnomAD4 genome
AF:
0.000381
AC:
58
AN:
152178
Hom.:
0
Cov.:
32
AF XY:
0.000404
AC XY:
30
AN XY:
74336
show subpopulations
Gnomad4 AFR
AF:
0.000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000622
Gnomad4 FIN
AF:
0.0000943
Gnomad4 NFE
AF:
0.000647
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000655
Hom.:
0
Bravo
AF:
0.000382
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00128
AC:
11
ExAC
AF:
0.000469
AC:
57
EpiCase
AF:
0.000927
EpiControl
AF:
0.000771

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:7Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:3Benign:3
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Aug 15, 2017- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicSep 01, 2022- -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxNov 22, 2023In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 27, 2023- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpAug 06, 2024Variant summary: ABCG8 c.1160C>T (p.Pro387Leu) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00048 in 250998 control chromosomes in the gnomAD database, including 1 homozygotes. This frequency is not significantly higher than estimated for a pathogenic variant in ABCG8 causing Early Onset Coronary Artery Disease (0.00048 vs 0.005), allowing no conclusion about variant significance. c.1160C>T has been reported in the literature in individuals affected with Familial Hypercholesterolemia (Reeskamp_2020). These report(s) do not provide unequivocal conclusions about association of the variant with Early Onset Coronary Artery Disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 32088153). ClinVar contains an entry for this variant (Variation ID: 500519). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Sitosterolemia 1 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingRevvity Omics, RevvitySep 25, 2023- -
Sitosterolemia;C1969115:Gallbladder disease 4 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 31, 2018- -
ABCG8-related disorder Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesAug 19, 2024The ABCG8 c.1160C>T variant is predicted to result in the amino acid substitution p.Pro387Leu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.10% of alleles in individuals of South Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsMay 17, 2024This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
0.023
DANN
Benign
0.74
DEOGEN2
Benign
0.31
.;T;T
Eigen
Benign
-1.7
Eigen_PC
Benign
-1.9
FATHMM_MKL
Benign
0.012
N
LIST_S2
Benign
0.42
T;.;T
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.039
T;T;T
MetaSVM
Benign
-0.48
T
MutationAssessor
Benign
1.1
.;L;L
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-1.0
.;.;N
REVEL
Benign
0.26
Sift
Benign
0.23
.;.;T
Sift4G
Benign
0.28
.;.;T
Polyphen
0.49
.;P;P
Vest4
0.10
MVP
0.42
MPC
0.016
ClinPred
0.022
T
GERP RS
-9.6
Varity_R
0.027
gMVP
0.41

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs150654176; hg19: chr2-44099394; COSMIC: COSV105060082; API